Home/Filings/4/0000917520-24-000004
4//SEC Filing

DAVIS ROBERT T. JR. 4

Accession 0000917520-24-000004

CIK 0000917520other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 4:43 PM ET

Size

5.0 KB

Accession

0000917520-24-000004

Insider Transaction Report

Form 4
Period: 2024-02-20
DAVIS ROBERT T. JR.
Corp VP, Pres. Neurosurgery
Transactions
  • Award

    Common Stock

    2024-02-20+3,72149,505 total
Footnotes (1)
  • [F1]On February 20, 2024, the Compensation Committee certified that the Company met or exceeded the average three-year annual organic revenue growth rate target for the performance period under the March 12, 2021 performance stock award. Accordingly, shares will vest on March 12, 2024, the third anniversary of the grant date.

Issuer

INTEGRA LIFESCIENCES HOLDINGS CORP

CIK 0000917520

Entity typeother

Related Parties

1
  • filerCIK 0001563606

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:43 PM ET
Size
5.0 KB